Delivery Order SPE2DB20D2104-SPE2DB23FT69G
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,456.80, is for the delivery of Losartan Potassium 100 mg tablets in 90-count packages. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,142.12 firm fixed-price delivery order is for the supply of 1,000 units of Losartan Potassium 100 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,114.71, is for the delivery of Losartan Potassium 100 mg Tablets in 1,000 count quantities. The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Losartan Potassium 100 mg tablets. The contract has a ceiling value of $3,473.52 and is a delivery order with a firm fixed price. The contract has an ultimate completion date of September 10, 2024. This award does not utilize any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,564,840 units of Losartan Potassium 100 mg tablets. The contract has a ceiling value of $2,179.10 and a completion date of June 10, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,450.90, is a delivery order for the supply of Losartan Potassium 50 mg Tablets in 1,000-count packages. The contract has an ultimate completion date of November 29, 2024, and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.81, is a delivery order for 4,563,927,418 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of March 12, 2024 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 1,000 units of Losartan Potassium 100 mg tablets. The contract has a fixed-price, delivery order structure with a ceiling value of $2,330.64 and a completion date of July 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order worth $1,495.76, is for the supply of 4,566,599 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of December 4, 2024 and is a Firm Fixed Price agreement. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This federal contract award, valued at $8,750.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,969,107 units of the medication Losartan Potassium 100 mg Tablets, with an ultimate completion date of April 21, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT69GDelivery Order
This federal contract award, with a ceiling value of $2,153.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan Potassium 100 mg tablets, with a period of performance through May 26, 2023. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award did not have a set-aside designation, indicating open competition.